March 5, 2025 · Form 4 insider transaction
Dhadha Ajay Kumar bought 350,000 shares of Raphael Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.